An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors

被引:24
|
作者
Patel, Ami V. [1 ]
Chaney, Katherine E. [1 ]
Choi, Kwangmin [1 ]
Largaespada, David A. [3 ]
Kumar, Ashish R. [2 ]
Ratner, Nancy [1 ]
机构
[1] Univ Cincinnati, Cincinnati Childrens Hosp, Div Expt Hematol & Canc Biol, Dept Pediat, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Cincinnati Childrens Hosp, Div Bone Marrow Transplantat & Immune Deficiency, Dept Pediat, Cincinnati, OH 45229 USA
[3] Univ Minnesota, Dept Pediat, Masonic Canc Ctr, Minneapolis, MN 55455 USA
来源
EBIOMEDICINE | 2016年 / 9卷
关键词
MPNST; MEIS1; ID1; RNAi; p27(Kip); G0/G1; arrest; Sarcoma; NEUROFIBROMATOSIS TYPE-1 GENE; SELF-RENEWAL; STEM-CELLS; RNA INTERFERENCE; SCHWANN-CELLS; CANCER; LEUKEMIA; TRANSFORMATION; TUMORIGENESIS; EXPRESSION;
D O I
10.1016/j.ebiom.2016.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant peripheral nerve sheath tumors (MPNST) are rare soft tissue sarcomas that are a major source of mortality in neurofibromatosis type 1 (NF1) patients. To identify MPNST driver genes, we performed a lentiviral short hairpin (sh) RNA screen, targeting all 130 genes up-regulated in neurofibroma and MPNSTs versus normal human nerve Schwann cells. NF1 mutant cells show activation of RAS/MAPK signaling, so a counter-screen in RAS mutant carcinoma cells was performed to exclude common RAS-pathway driven genes. We identified 7 genes specific for survival of MPSNT cells, including MEIS1. MEIS1 was frequently amplified or hypomethylated in human MPSNTs, correlating with elevated MEIS1 gene expression. In MPNST cells and in a genetically engineered mouse model, MEIS1 expression in developing nerve glial cells was necessary for MPNST growth. Mechanistically, MEIS1 drives MPNST cell growth via the transcription factor ID1, thereby suppressing expression of the cell cycle inhibitor p27(Kip) and maintaining cell survival. (C) 2016 Published by Elsevier B.V.
引用
收藏
页码:110 / 119
页数:10
相关论文
共 50 条
  • [1] Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis
    Danielsen, Stine A.
    Lind, Guro E.
    Kolberg, Matthias
    Holand, Maren
    Bjerkehagen, Bodil
    Hall, Kirsten Sundby
    van den Berg, Eva
    Mertens, Fredrik
    Smeland, Sigbjorn
    Picci, Piero
    Lothe, Ragnhild A.
    NEURO-ONCOLOGY, 2015, 17 (01) : 63 - 69
  • [2] Malignant peripheral nerve sheath tumors in neurofibromatosis 1
    King, AA
    DeBaun, RR
    Riccardi, VM
    Gutmann, DH
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 93 (05): : 388 - 392
  • [3] Malignant Peripheral Nerve Sheath Tumors
    Farid, Mohamad
    Demicco, Elizabeth G.
    Garcia, Roberto
    Ahn, Linda
    Merola, Pamela R.
    Cioffi, Angela
    Maki, Robert G.
    ONCOLOGIST, 2014, 19 (02) : 193 - 201
  • [4] Malignant Peripheral Nerve Sheath Tumors
    Durbin, Adam D.
    Ki, Dong Hyuk
    He, Shuning
    Look, A. Thomas
    CANCER AND ZEBRAFISH: MECHANISMS, TECHNIQUES, AND MODELS, 2016, 916 : 495 - 530
  • [5] Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis
    Rahrmann, Eric P.
    Watson, Adrienne L.
    Keng, Vincent W.
    Choi, Kwangmin
    Moriarity, Branden S.
    Beckmann, Dominic A.
    Wolf, Natalie K.
    Sarver, Aaron
    Collins, Margaret H.
    Moertel, Christopher L.
    Wallace, Margaret R.
    Gel, Bernat
    Serra, Eduard
    Ratner, Nancy
    Largaespada, David A.
    NATURE GENETICS, 2013, 45 (07) : 756 - +
  • [6] Therapeutic targets for malignant peripheral nerve sheath tumors
    Wu, Lai Man Natalie
    Lu, Qing Richard
    FUTURE NEUROLOGY, 2019, 14 (01)
  • [7] Ral Overactivation in Malignant Peripheral Nerve Sheath Tumors
    Bodempudi, Vidya
    Yamoutpoor, Farnaz
    Pan, Weihong
    Dudek, Arkadiusz Z.
    Esfandyari, Tuba
    Piedra, Mark
    Babovick-Vuksanovic, Dusica
    Woo, Richard A.
    Mautner, Victor F.
    Kluwe, Lan
    Clapp, D. Wade
    DeVries, George H.
    Thomas, Stacey L.
    Kurtz, Andreas
    Parada, Luis F.
    Farassati, Faris
    MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (14) : 3964 - 3974
  • [8] MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors
    Gong, Meng
    Ma, Junrong
    Li, Mi
    Zhou, Mingliang
    Hock, Janet M.
    Yu, Xijie
    NEURO-ONCOLOGY, 2012, 14 (08) : 1007 - 1017
  • [9] Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas
    Pekmezci, Melike
    Reuss, David E.
    Hirbe, Angela C.
    Dahiya, Sonika
    Gutmann, David H.
    von Deimling, Andreas
    Horvai, Andrew E.
    Perry, Arie
    MODERN PATHOLOGY, 2015, 28 (02) : 187 - 200
  • [10] Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors
    L'Heureux-Lebeau, Benedicte
    Saliba, Issam
    ONCOTARGETS AND THERAPY, 2013, 6 : 459 - 470